Ophthalmology Perspectives

Fortrea
  • 0,0 (0)
  • Geneeskunde

Here we explore the evolving landscape of ophthalmology clinical trials and look ahead to the most promising trends shaping the future of ophthalmology trials.

Afleveringen

  1. 20 mrt

    Ophthalmology Perspectives | Ep 3 | Gene Therapy, Patient-Centric Operations, and Risk-Benefit Challenges in Phase 1 Ophthalmology Trials

    Today we explore the unique challenges and opportunities in Phase 1 ophthalmology clinical trials, focusing on gene therapy and inherited retinal diseases.

  2. 20 mrt

    Ophthalmology Perspectives | Ep 2 | Ophthalmology Trials at the Leeds CPU

    In today’s episode, we delve into the fascinating world of Phase 1 clinical research at Fortrea’s Leeds Clinical Pharmacology Unit in the UK. We explore the operational challenges and innovative solutions behind a recent, complex ophthalmology clinical trial.

  3. 20 mrt

    Ophthalmology Perspectives | Ep 1 | Patient Recruitment in Ophthalmology Trials

    In this conversation, we to dive into the evolving landscape of patient recruitment in ophthalmology and explore how Belite Bio and Fortrea are collaborating to overcome protocol complexities, and discuss the unique opportunities Asia PAC represents for ocular development. We'll also look ahead to the most promising trends shaping the future of ophthalmology trials.

  • 3 afleveringen

Info

Here we explore the evolving landscape of ophthalmology clinical trials and look ahead to the most promising trends shaping the future of ophthalmology trials.

Informatie